BCL2L1 and colonic neoplasm: The findings that Bcl-xL is the major suppressor of apoptosis following treatment by alisertib and that ABT-737 cooperates with alisertib in apoptosis induction in colon cancer cells raise the possibility that senescent cancer cells are mainly kept alive by Bcl-xL.